In vitro studies on clonal growth of chondrocytes in thanatophoric dysplasia

American Journal of Medical Genetics

Volumn 63, Issue 2, 1996, Pages 401-405

  Brenner, Rolf E ^a,d   Nerlich, Andreas ^b   Terinde, Rainer ^c   Bartmann, Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

bFGF; chondrocyte; clonal growth; IGF I; IGF II; TGF b; thanatophoric dysplasia

Indexed keywords

ARTICLE; BONE DYSPLASIA; CARTILAGE CELL; CELL GROWTH; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GROWTH PLATE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUNG HYPOPLASIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THANATOPHORIC DWARFISM;

CARTILAGE, ARTICULAR; CELL DIVISION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; THANATOPHORIC DYSPLASIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029998235     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960517)63:2<401::AID-AJMG15>3.0.CO;2-O     Document Type: Article

References (22)

1. Bellus GA, McIntosch I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenshaw GA, Hecht JT, Francomano CA (1995): A recurrent mutation in the tyrosin kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genet 10: 357-359.
2. Brenner RE, Nerlich A, Heinze E, Vetter U, Teller WM (1993): Different regulation of clonal growth by transforming growth factor-β1 in human fetal articular and costal chondrocytes. Pediatr Res 33: 390-393.
3. Connor JM, Connor RAC, Sweet EM, Gibson AAM, Patrick WJA, McNay MB, Redford DHA (1985): Lethal neonatal chondrodysplasias in the west of Scotland 1979-1983 with a description of a thanatophoric dysplasialike, autosomal recessive disorder, Glasgow variant. Am J Med Genet 22:243-253.
4. Horton WA, Campbell DC, Machado MA, Chou J (1989): Type II collagen screening in the human chondrodysplasias. Am J Med Genet 34:579-583.
5. Massague J (1992): Receptors for the TGF-β family. Cell 69:1067-1070.
6. Ornoy A, Adomian GE, Eteson DJ, Burgeson RE, Rimoin DL (1985): The role of mesenchyme-like tissue in the pathogenesis of thanatophoric dysplasia. Am J Med Genet 21:613-630.
7. Peters K, Ornitz D, Werner S, Williams L (1993): Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 155:423-430.
8. Rimoin DL (1975): The Chondrodystrophies. Advances in human genetics 5:1-118.
9. Rousseau F, Bonaventure J, Legeal-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A (1994): Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-254.
10. Rousseau F, Saugier P, Le Merrer M, Munnich A, Delezoide AL, Maroteaux P, Bonaventure J (1995): Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nature Genet 10:11-12.
11. Shiang R, Thompson LM, Zhu Y, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ (1994): Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
12. Sillence DO, Horton WA, Rimoin DL (1979): Morphologic studies in the skeletal dysplasias. Am J Pathol 96:813-859.
13. Spranger J (1985): Pattern recognition in bone dysplasias. "Endocrine Genetics and Genetics of Growth." New York: Alan R. Liss, Inc., 315-342.
14. Spranger J, Maroteaux P (1990): The Lethal Osteochondrodysplasias: "Advances in human genetics." Harris H, Hirschhorn K (eds). New York/London: Plenum Press, pp 1-103.
15. Stanescu V, Stanescu R, Maroteaux P (1991): Type II collagen and noncollagenous protein screening in the human chondrodysplasias. Am J Med Genet 39:373.
16. Stanescu V, Do TP, Chaminade F, Maroteaux P, Stanescu R (1994): Non-collagenous protein screening in the human chondrodysplasias: link proteins, cartilage oligomeric matrix protein (COMP), and fibromodulin. Am J Med Genet 51:22-28.
17. Stensvold K, Ek J, Hovland AR (1986): An infant with thanatophoric dwarfism surviving 169 days. Clin Genet 29:157-159.
18. Stoilov I, Kilpatrick MW, Tsipouras P (1995): A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia. Am J Med Genet 55:127-133.
19. Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ (1995): Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet 9:321-328.
20. Ullrich A, Schlessinger J (1990): Signal transduction by receptors with tyrosin kinase activity. Cell 61:203-212.
21. Vetter U, Zapf J, Heit W, Helbing G, Heinze E, Froesch RE, Teller WM (1986): Human fetal and adult chondrocytes: Effect of insulinlike growth factors I and II, insulin and growth hormone on clonal growth. J Clin Invest 77:1903-1908.
22. Yang SS, Heidelberger KP, Brough AJ, Corbett DP, Bernstein J (1976): Lethal short-limbed chondrodysplasia in early infancy. Perspect Pediatr Pathol 3:1-40.